On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

CNS Pharmaceuticals Inc. (NASDAQ: CNSP) is “One to Watch”

CNS Pharmaceuticals’ lead drug candidate, Berubicin, is proposed for the treatment of glioblastoma multiforme (“GBM”), an aggressive and currently incurable form of brain cancer. In a Phase I clinical trial of Berubicin in malignant brain tumors, 44% of patients experienced a statistically significant improvement in clinical benefit. In preclinical studies, the company’s second drug candidate, […]

Pac Roots Cannabis Corp. (CSE: PACR) Leverages Expertise, Resources to Establish Dominant Position in Growing Cannabis Market

Legal marijuana market set to top more than $90 billion by 2027 Pac Roots places top priority on developing, delivering finest cannabis genetics Optimized farming systems employed in most fertile areas means maximum opportunity for harvest After experiencing a few roadblocks over the last year, the cannabis sector looks to be picking up speed. In […]

180 Life Sciences Corp. Leading Research into Novel Drug Therapies Expected to Produce First Results of Phase 2b/3 Trial in 2021

Anti-inflammatory therapeutics market to generate revenues of $191.42 billion through 2027 Novel drug therapy for Fibrosis and Anti-TNF trials being conducted by Professor Sir Marc Feldmann, who already developed one of the most commonly used anti-TNF medications, Remicade The number of conditions with chronic inflammation is expected to increase persistently over the next 30 years […]

Sanwire Corp. (SNWR) is “One to Watch”

Sanwire Corp. is using technology to consolidate services in fragmented markets. The company is currently focused on advanced entertainment technologies. The acquisition of Intercept Music Inc. gave Sanwire solid footing in the music and entertainment industry, offering a unique suite of artist-focused services specifically created for recording artists. During the second quarter of 2020, Sanwire’s […]

Predictive Oncology Inc.’s (NASDAQ: POAI) Soluble Biotech Inks Major Contract; Skyline Medical Seals STREAMWAY Deal

POAI’s Soluble Biotech announces first substantial contract with pharmaceutical company since acquisition Founder calls contract “major milestone,” validation of move into new facility POAI’s Skyline Medical sells eight proprietary STREAMWAY(R) systems to Virginia-based hospital organization Soluble Biotech, a division of Predictive Oncology (NASDAQ: POAI), has finalized its first substantial contract with a pharmaceutical company since […]

In Wake of Hurricane Laura, Sustainable Green Team Ltd. (SGTM) Plays Pivotal Role in Relief Support

SGTM secures Hurricane Laura recovery work contract for ArborPro of Mississippi Inc. Initial relief efforts will divert trees from landfills to temporary holding sites SGTM transforms natural storm waste into organic environmentally beneficial products As “stewards of the environment”, Sustainable Green Team (OTC: SGTM) takes its role in environmental remediation seriously by providing beneficial solutions […]

Trxade Group Inc. (NASDAQ: MEDS) Pharmaceutical Supply Chain Trading Platform Gives Independent Drugstores a New Lease on Life

Pressing need for efficient drug procurement, delivery as costs rise Trxade platform speeds up delivery, cuts costs Such efficiencies crucial to keeping America’s independent pharmacies alive Around half of 24,000 independent pharmacies have already signed on These days, critics of the U.S. health-care system may be tempering their censure. After all, the sector has proved […]

Kaival Brands Innovations Group Inc. (KAVL) Seeks to Bring Innovative New Offering to Vape Scene

KAVL recently announced the Bidi(TM) Vapor Premarket Tobacco Product Application submission to FDA, a premium recyclable vape pen Application includes 285,000 pages with science-backed evidence that Bidi(TM) Sticks are Appropriate for Protection of Public Health (“APPH”) KAVL and Bidi(TM) Vapor fully support proper regulation of safety manufacturing and marketing of vape products Bidi(TM) Sticks are […]

GoldHaven Resources Corp. (CSE: GOH) (OTCQB: ATUMF) Trades on OTCQB, Creating Early Opportunity for American Investors

GoldHaven to trade on OTCQB under ticker symbol ATUMF Move provides liquidity in trading of shares, creates opportunity for American investors to participate in Maricunga Gold Belt activity GoldHaven recently entered into agreements to acquire seven gold projects, plans aggressive drill program GoldHaven Resources (CSE: GOH) (OTCQB: ATUMF), a Canada-based company engaged in the business […]

 

From Our Blog

CNS Pharmaceuticals Inc. (NASDAQ: CNSP) is “One to Watch”

September 25, 2020

CNS Pharmaceuticals’ lead drug candidate, Berubicin, is proposed for the treatment of glioblastoma multiforme (“GBM”), an aggressive and currently incurable form of brain cancer. In a Phase I clinical trial of Berubicin in malignant brain tumors, 44% of patients experienced a statistically significant improvement in clinical benefit. In preclinical studies, the company’s second drug candidate, […]

Rotate your device 90° to view site.